These results suggest that HFD induced obesity can lead to the occurrence of OA, and resveratrol may alleviate OA pathology by decreasing the levels of systematic inflammation and/or inhibiting TLR4 signaling pathway in cartilage. This evidence concerns the gene TLR4 and obesity due to melanocortin 4 receptor deficiency.